• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HLA - E是自然杀伤细胞抑制性受体CD94/NKG2A的主要配体。

HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A.

作者信息

Lee N, Llano M, Carretero M, Ishitani A, Navarro F, López-Botet M, Geraghty D E

机构信息

The Clinical Research Division, Fred Hutchinson Cancer Research Center, 1124 Columbia St., M374, Seattle, WA 98104-2092, USA.

出版信息

Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5199-204. doi: 10.1073/pnas.95.9.5199.

DOI:10.1073/pnas.95.9.5199
PMID:9560253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC20238/
Abstract

We previously showed that the availability of a nonamer peptide derived from certain HLA class I signal sequences is a necessary requirement for the stabilization of endogenous HLA-E expression on the surface of 721.221 cells. This led us to examine the ability of HLA-E to protect HLA class I transfectants from natural killer (NK) cell-mediated lysis. It was possible to implicate the CD94/NKG2A complex as an inhibitory receptor recognizing this class Ib molecule by using as target a .221 transfectant selectively expressing surface HLA-E. HLA-E had no apparent inhibitory effect mediated through the identified Ig superfamily (Ig-SF) human killer cell inhibitory receptors or ILT2/LIR1. Further studies of CD94/NKG2+ NK cell-mediated recognition of .221 cells transfected with different HLA class I allotypes (i.e., -Cw4, -Cw3, -B7) confirmed that the inhibitory interaction was mediated by CD94/NKG2A recognizing the surface HLA-E molecule, because only antibodies directed against either HLA-E, CD94, or CD94/NKG2A specifically restored lysis. Surface stabilization of HLA-E in cold-treated .221 cells loaded with appropriate peptides was sufficient to confer protection, resulting from recognition of the HLA class Ib molecule by the CD94/NKG2A inhibitory receptor. Consistent with the prediction that the ligand for CD94/NKG2A is expressed ubiquitously, our examination of HLA-E antigen distribution indicated that it is detectable on the surface of a wide variety of cell types.

摘要

我们之前的研究表明,源自某些HLA I类信号序列的九聚体肽的可用性是721.221细胞表面内源性HLA-E表达稳定的必要条件。这促使我们研究HLA-E保护HLA I类转染细胞免受自然杀伤(NK)细胞介导的裂解的能力。通过使用选择性表达表面HLA-E的.221转染细胞作为靶标,有可能将CD94/NKG2A复合物作为识别这种Ib类分子的抑制性受体。HLA-E通过已鉴定的免疫球蛋白超家族(Ig-SF)人类杀伤细胞抑制性受体或ILT2/LIR1没有明显的抑制作用。对CD94/NKG2+NK细胞介导的对转染了不同HLA I类同种异型(即-Cw4、-Cw3、-B七)的.221细胞的识别的进一步研究证实,抑制性相互作用是由识别表面HLA-E分子的CD94/NKG2A介导的,因为只有针对HLA-E、CD94或CD94/NKG2A的抗体才能特异性恢复裂解。在加载适当肽的冷处理.221细胞中HLA-E的表面稳定足以赋予保护作用,这是由于CD94/NKG2A抑制性受体识别了HLA Ib类分子。与CD94/NKG2A的配体普遍表达的预测一致,我们对HLA-E抗原分布的检查表明,它在多种细胞类型的表面均可检测到。

相似文献

1
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A.HLA - E是自然杀伤细胞抑制性受体CD94/NKG2A的主要配体。
Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5199-204. doi: 10.1073/pnas.95.9.5199.
2
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.人类白细胞抗原E(HLA-E)与自然杀伤细胞受体CD94/NKG2A、B及C相结合。
Nature. 1998 Feb 19;391(6669):795-9. doi: 10.1038/35869.
3
The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells.ILT2(LIR1)和CD94/NKG2A自然杀伤细胞受体分别识别在靶细胞上共表达的HLA-G1和HLA-E分子。
Eur J Immunol. 1999 Jan;29(1):277-83. doi: 10.1002/(SICI)1521-4141(199901)29:01<277::AID-IMMU277>3.0.CO;2-4.
4
HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.人类自然杀伤细胞对HLA - G的识别。CD94作为抑制性和激活性受体复合物的参与情况。
Eur J Immunol. 1997 Aug;27(8):1875-80. doi: 10.1002/eji.1830270809.
5
Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.可溶性CD94/NKG2A和自然杀伤细胞对HLA-E具有特异性识别,而对经典的HLA I类分子则无此识别。
J Immunol. 1999 Jan 1;162(1):305-13.
6
Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.抑制性自然杀伤细胞受体CD94/NKG2 - A和激活受体CD94/NKG2 - C与HLA - E结合的动力学及肽依赖性
EMBO J. 1999 Aug 2;18(15):4250-60. doi: 10.1093/emboj/18.15.4250.
7
HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer.与HLA-E结合的肽段影响抑制性和激活性CD94/NKG2受体的识别:对一种源自HLA-G的九聚体的优先反应。
Eur J Immunol. 1998 Sep;28(9):2854-63. doi: 10.1002/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W.
8
Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.CD94/NKG2对与I类组织相容性白细胞抗原(HLA)-E复合的HLA I类信号序列衍生肽的识别赋予了对自然杀伤细胞介导的细胞溶解的保护作用。
J Exp Med. 1998 Mar 2;187(5):813-8. doi: 10.1084/jem.187.5.813.
9
Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: evidence for receptor function in heterologous transfectants.HLA-E Ib类分子与CD94/NKG2-A杀伤抑制性受体的特异性结合诱导SHP-1磷酸酶募集至酪氨酸磷酸化的NKG2-A:异源转染子中受体功能的证据
Eur J Immunol. 1998 Apr;28(4):1280-91. doi: 10.1002/(SICI)1521-4141(199804)28:04<1280::AID-IMMU1280>3.0.CO;2-O.
10
Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2.HLA-E肽结合特异性及CD94/NKG2识别所需结合肽中接触残基的分析。
J Immunol. 2003 Aug 1;171(3):1369-75. doi: 10.4049/jimmunol.171.3.1369.

引用本文的文献

1
Targeting MHC-E as a new strategy for vaccines and immunotherapeutics.将MHC-E作为疫苗和免疫疗法的新策略。
Nat Rev Immunol. 2025 Sep 3. doi: 10.1038/s41577-025-01218-6.
2
An In-Depth Review of the Genetics of the Non-Classical HLA Class I Gene HLA-E and Its Effects on Haematopoietic Cell Transplant Outcomes.非经典 HLA I 类基因 HLA-E 的遗传学及其对造血细胞移植结果影响的深入综述
HLA. 2025 Aug;106(2):e70344. doi: 10.1111/tan.70344.
3
Innate-like memory T cells rapidly emerge in humans after gene therapy for SCID-X1.在对重症联合免疫缺陷X1型(SCID-X1)进行基因治疗后,类先天性记忆T细胞在人类体内迅速出现。
Immunity. 2025 Jul 31. doi: 10.1016/j.immuni.2025.07.002.
4
Macrophage Migration Inhibitory Factor Suppresses Natural Killer Cell Response and Promotes Hypoimmunogenic Stem Cell Engraftment Following Spinal Cord Injury.巨噬细胞移动抑制因子抑制自然杀伤细胞反应并促进脊髓损伤后低免疫原性干细胞植入。
Biology (Basel). 2025 Jun 30;14(7):791. doi: 10.3390/biology14070791.
5
Human iPSC-derived NK cells armed with CCL19, CCR2B, high-affinity CD16, IL-15, and NKG2D complex enhance anti-solid tumor activity.携带CCL19、CCR2B、高亲和力CD16、IL-15和NKG2D复合物的人诱导多能干细胞衍生的自然杀伤细胞增强抗实体瘤活性。
Stem Cell Res Ther. 2025 Jul 15;16(1):373. doi: 10.1186/s13287-025-04461-9.
6
Macrophage Migration Inhibitory Factor Suppresses Natural Killer Cell Response and Promotes Hypoimmunogenic Stem Cell Engraftment Following Spinal Cord Injury.巨噬细胞迁移抑制因子抑制自然杀伤细胞反应并促进脊髓损伤后低免疫原性干细胞植入。
bioRxiv. 2025 May 7:2025.05.06.652516. doi: 10.1101/2025.05.06.652516.
7
Sensitization in Transplantation Assessment of Risk 2025 innate working group: The potential role of innate allorecognition in kidney allograft damage.2025年移植风险评估中的固有免疫工作组:固有同种异体识别在肾移植损伤中的潜在作用。
Am J Transplant. 2025 Jul 5. doi: 10.1016/j.ajt.2025.06.030.
8
Power of Memory: A Natural Killer Cell Perspective.记忆的力量:自然杀伤细胞视角
Cells. 2025 Jun 5;14(11):846. doi: 10.3390/cells14110846.
9
Human Cytomegalovirus Antigen Presentation by HLA-G in Infected Cells.人巨细胞病毒抗原在感染细胞中由HLA-G呈递
HLA. 2025 May;105(5):e70089. doi: 10.1111/tan.70089.
10
Natural killer cell-based immunotherapy for cancer.基于自然杀伤细胞的癌症免疫疗法。
J Immunol. 2025 Apr 17. doi: 10.1093/jimmun/vkaf036.

本文引用的文献

1
HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences.HLA-E 表面表达取决于源自某些 HLA I 类信号序列的 TAP 依赖性肽段的结合。
J Immunol. 1998 May 15;160(10):4951-60.
2
Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: evidence for receptor function in heterologous transfectants.HLA-E Ib类分子与CD94/NKG2-A杀伤抑制性受体的特异性结合诱导SHP-1磷酸酶募集至酪氨酸磷酸化的NKG2-A:异源转染子中受体功能的证据
Eur J Immunol. 1998 Apr;28(4):1280-91. doi: 10.1002/(SICI)1521-4141(199804)28:04<1280::AID-IMMU1280>3.0.CO;2-O.
3
What goes up must come down: the emerging spectrum of inhibitory receptors.上升者必将下降:抑制性受体的新兴谱系。
J Exp Med. 1997 Dec 1;186(11):1803-8. doi: 10.1084/jem.186.11.1803.
4
A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells.人类淋巴细胞和髓单核细胞上主要组织相容性复合体I类分子的一种常见抑制性受体。
J Exp Med. 1997 Dec 1;186(11):1809-18. doi: 10.1084/jem.186.11.1809.
5
HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.人类自然杀伤细胞对HLA - G的识别。CD94作为抑制性和激活性受体复合物的参与情况。
Eur J Immunol. 1997 Aug;27(8):1875-80. doi: 10.1002/eji.1830270809.
6
A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules.一种新型的细胞和病毒MHC I类分子免疫球蛋白超家族受体。
Immunity. 1997 Aug;7(2):273-82. doi: 10.1016/s1074-7613(00)80529-4.
7
CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells.CD94/NKG2是蜕膜和外周血自然杀伤细胞识别HLA-G所涉及的主要抑制性受体。
J Immunol. 1997 Aug 1;159(3):1072-5.
8
The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.CD94/NKG2-A抑制性受体复合物参与自然杀伤细胞介导的对表达HLA-G1细胞的识别。
J Immunol. 1997 Jun 15;158(12):5736-43.
9
A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter.一种病毒内质网驻留糖蛋白可使主要组织相容性复合体(MHC)编码的肽转运体失活。
Immunity. 1997 May;6(5):623-32. doi: 10.1016/s1074-7613(00)80350-7.
10
Natural killer cells: from no receptors to too many.自然杀伤细胞:从无受体到受体过多。
Immunity. 1997 Apr;6(4):371-8. doi: 10.1016/s1074-7613(00)80280-0.